documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where docket_id = "FDA-2003-D-0244" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-D-0244-0006 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 Guidance Supporting & Related Material GDL-Guidance 2005-06-21T04:00:00Z 2005 6     2008-04-12T00:55:07Z   0 0 090000648048ed39
FDA-2003-D-0244-0004 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 Guidance Supporting & Related Material GDL-Guidance 2005-06-21T04:00:00Z 2005 6     2008-04-12T00:55:07Z   0 0 090000648048ed19
FDA-2003-D-0244-0007 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 FDA Notice NAD-Notice of Availability of Data 2005-06-21T04:00:00Z 2005 6 2005-06-20T04:00:00Z 2006-06-21T03:59:59Z 2008-04-12T00:55:07Z   0 0 090000648048ed3e
FDA-2003-D-0244-0005 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 Guidance Supporting & Related Material GDL-Guidance 2005-06-21T04:00:00Z 2005 6     2008-04-12T00:55:07Z   0 0 090000648048ed36
FDA-2003-D-0244-0001 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 FDA Notice NAD-Notice of Availability of Data 2003-12-30T05:00:00Z 2003 12 2003-12-30T05:00:00Z 2004-03-02T04:59:59Z 2008-04-12T00:55:07Z   0 0 090000648048ecd0
FDA-2003-D-0244-0003 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 Guidance Supporting & Related Material GDL-Guidance 2003-12-30T05:00:00Z 2003 12     2008-04-12T00:55:07Z   0 0 090000648048ed15
FDA-2003-D-0244-0002 FDA Draft Guidance for Industry: Clozapine Tablets: In Vivo Bioequivalence and In Vitro Dissolution Testing, Revision FDA-2003-D-0244 Guidance Supporting & Related Material GDL-Guidance 2003-12-30T05:00:00Z 2003 12     2008-04-12T00:55:07Z   0 0 090000648048ecfe

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);